290 related articles for article (PubMed ID: 17510705)
1. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells.
Foubert P; Silvestre JS; Souttou B; Barateau V; Martin C; Ebrahimian TG; Leré-Déan C; Contreres JO; Sulpice E; Levy BI; Plouët J; Tobelem G; Le Ricousse-Roussanne S
J Clin Invest; 2007 Jun; 117(6):1527-37. PubMed ID: 17510705
[TBL] [Abstract][Full Text] [Related]
2. [Improved angiogenesis by P-selectin glycoprotein ligand-1 overexpression in endothelial progenitor cells].
Li L; Huang L; Yang H; Yin HC
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):621-6. PubMed ID: 21092591
[TBL] [Abstract][Full Text] [Related]
3. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis.
Limbourg A; Ploom M; Elligsen D; Sörensen I; Ziegelhoeffer T; Gossler A; Drexler H; Limbourg FP
Circ Res; 2007 Feb; 100(3):363-71. PubMed ID: 17234965
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of P-selectin glycoprotein ligand-1 enhances adhesive properties of endothelial progenitor cells through Syk activation.
Cao L; Li L; Yang H; Yin H
Acta Biochim Biophys Sin (Shanghai); 2010 Aug; 42(8):507-14. PubMed ID: 20705591
[TBL] [Abstract][Full Text] [Related]
5. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
6. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
7. NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37.
Pfosser A; El-Aouni C; Pfisterer I; Dietz M; Globisch F; Stachel G; Trenkwalder T; Pinkenburg O; Horstkotte J; Hinkel R; Sperandio M; Hatzopoulos AK; Boekstegers P; Bals R; Kupatt C
Stem Cells; 2010 Feb; 28(2):376-85. PubMed ID: 20014279
[TBL] [Abstract][Full Text] [Related]
8. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
Bai J; Wang YJ; Liu L; Zhao YL
J Int Med Res; 2014 Apr; 42(2):405-15. PubMed ID: 24517927
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation.
Yang C; Zhang ZH; Li ZJ; Yang RC; Qian GQ; Han ZC
Thromb Haemost; 2004 Jun; 91(6):1202-12. PubMed ID: 15175808
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia.
Katsu M; Koyama H; Maekawa H; Kurihara H; Uchida H; Hamada H
J Vasc Surg; 2009 Jan; 49(1):192-8. PubMed ID: 18950979
[TBL] [Abstract][Full Text] [Related]
12. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
[TBL] [Abstract][Full Text] [Related]
13. Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
Crnkovic S; Rittchen S; Jandl K; Gindlhuber J; Zabini D; Mutgan AC; Valzano F; Boehm PM; Hoetzenecker K; Toller W; Veith C; Heinemann A; Schermuly RT; Olschewski A; Marsh LM; Kwapiszewska G
Hypertension; 2023 Feb; 80(2):e17-e28. PubMed ID: 36519465
[TBL] [Abstract][Full Text] [Related]
14. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
[TBL] [Abstract][Full Text] [Related]
16. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
[TBL] [Abstract][Full Text] [Related]
17. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
18. Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.
Wong DJ; Lu DY; Protack CD; Kuwahara G; Bai H; Sadaghianloo N; Tellides G; Dardik A
J Vasc Surg; 2016 Mar; 63(3):795-804. PubMed ID: 25446283
[TBL] [Abstract][Full Text] [Related]
19. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
20. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
